Company intelligence / Profile preview
Incannex Healthcare
Sydney, Australiaincannex.com ↗
- Ownership
- Public · IXHL
- Employees
- ~9
- Development stage
- Phase 2
01
Overview
Clinical-stage biopharma developing oral fixed-dose combinations and psychedelic-assisted therapies, with lead programs in Phase23 trials for OSA and Phase2 trials for anxiety disorders.
- Therapeutic areas
- GastroenterologyPulmonologyPsychiatryImmunology
- Modalities
- Small moleculesCombination therapiesPsychedelic-assisted psychotherapy
- Industry
- Biotech
02
Drug pipeline
22 assets21 more assets in the full pipeline.
03
Partnerships
Arena Investors LP($60M financing)
04
Financials
- Market cap
- $27.2M
- Total revenue
- $0
- Enterprise value
- $-40.5M
Beyond the preview
Go deeper on Incannex Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Incannex Healthcare.